packageCapmatinib

capmatinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Capmatinib is a kinase inhibitor used to treat non-small-cell lung cancer. It is authorised in the European Union and is also being studied for other uses.

Summary written by glm-5.3-flash from Wikidata Q27075685 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:capmatinib
ATC codes:L01EP01, L01EX17
DrugBank:DB11791
PubChem CID:25145656
Wikidata:Q27075685
formula:C23H17FN6O
molar mass:412.428 g/mol (PubChem CID 25145656)
logP:2.9 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown